---
layout: post
title: "Determination That ROXICET (Oxycodone Hydrochloride and Acetaminophen) Tablet, 5 Milligrams and 325 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness"
date: 2026-02-04 21:48:59 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-14707
original_published: 2025-08-04 00:00:00 +0000
significance: 8.00
---

# Determination That ROXICET (Oxycodone Hydrochloride and Acetaminophen) Tablet, 5 Milligrams and 325 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

**Published:** February 04, 2026 21:48 UTC
**Source:** Federal Register
**Original Published:** August 04, 2025 00:00 UTC
**Document Number:** 2025-14707

## Summary

The Food and Drug Administration (FDA or Agency) has determined that ROXICET (oxycodone hydrochloride (HCl) and acetaminophen) tablet, 5 milligrams (mg)/325 mg, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for oxycodone HCl and acetaminophen tablet, 5 mg/ 325 mg, if all other legal and regulatory requirements are met.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/08/04/2025-14707/determination-that-roxicet-oxycodone-hydrochloride-and-acetaminophen-tablet-5-milligrams-and-325)
- API: https://www.federalregister.gov/api/v1/documents/2025-14707

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
